MP24-15 CLINICAL UTILITY OF DETECTING LOW-FREQUENCY CELL-FREE DNA VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER

2021 
INTRODUCTION AND OBJECTIVE:Plasma cell-free DNA (cfDNA) testing is emerging as a tool for precision medicine in castration-resistant prostate cancer (CRPC). However, circulating cell-free tumor DNA...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map